Sharon Maxwell, NP-C · Founder
Stem Cell Therapy in Draper, Utah (2026): Wharton's Jelly vs. Bone Marrow vs. Adipose, Real Pricing, and the FDA Reality
Short answer: Stem cell therapy in Utah ranges from $1,999 single-joint protocols to $10,000–$25,000+ comprehensive systemic protocols. The most common product offered locally is mesenchymal stem cells (MSCs) from Wharton's Jelly — gelatinous umbilical-cord tissue from healthy full-term births. This is not the same as the embryonic stem cell debate from the 2000s. The honest reality: stem cell injections are an active and rapidly evolving area of regenerative medicine where the FDA position is restrictive, the evidence is uneven, and the gap between marketing claims and published outcomes is wider than for any other treatment we offer.
I'm Sharon Maxwell, NP-C, founder of Elements Med Lounge in Draper, Utah. Stem cell protocols at our practice are medically directed by Dr. Richard Maxwell. This is the honest version of the conversation.
What "Stem Cells" Actually Means in 2026 Aesthetics & Regenerative Medicine
The term "stem cell" in U.S. regenerative medicine practice in 2026 almost always refers to mesenchymal stem cells (MSCs) — adult multipotent cells capable of differentiating into bone, cartilage, fat, and connective tissue, and (more importantly) secreting a paracrine cloud of growth factors and signaling molecules.
There are three major source categories:
| Source | What it is | Cell viability | Cost (U.S.) | Regulatory status |
|---|---|---|---|---|
| Wharton's Jelly (umbilical cord) | Allogeneic donor tissue from full-term births | Highest cell counts, youngest cells | $3,000–$10,000 per dose | Sold as "human cellular tissue product" — see FDA note below |
| Adipose-derived (your own fat) | Lipo-extracted, processed | Moderate | $5,000–$15,000+ | More than minimal manipulation generally restricted by FDA |
| Bone marrow concentrate | Aspirated from iliac crest | Moderate-low | $3,000–$10,000 | Permitted under FDA "same surgical procedure" exception when done in-office same day |
Stem cell injections are not the same as PRP (your own concentrated platelets) or exosomes (cell-secreted vesicles, often umbilical-derived). All three are sometimes used together; all three are different products with different evidence.
The FDA Reality Most Clinics Don't Discuss
This is the section that matters most for your safety:
In November 2021 the FDA's regulatory grace period for human cellular tissue products (HCT/Ps) ended. The agency's current position is that most allogeneic stem cell products marketed as therapies require an FDA-approved IND (Investigational New Drug application) — which the vast majority of U.S. clinic-sold products do not have. The FDA periodically sends warning letters to clinics marketing stem cell injections, and several enforcement actions have happened in the last 24 months.
Practical implications:
- Wharton's Jelly products are typically marketed not as "stem cell therapy" but as "human cellular tissue products" — a legal but narrower description.
- A reputable clinic will name the specific tissue product they use and the manufacturer.
- A reputable clinic will be honest with you that the FDA's position is restrictive and that you are receiving an investigational treatment that is not FDA-approved as a drug.
- Cell viability and counts vary widely between manufacturers. Some marketed "stem cell" products contain very few live cells — the active ingredient is the cytokine/growth-factor mix, which is closer to PRP physiology than true cell therapy.
Our practice's position: we follow current FDA guidance. We are transparent that human cellular tissue products are investigational. We do not promise specific outcomes, and we explicitly tell patients that the FDA does not consider these to be approved therapies. If a clinic is making confident claims about "stem cells curing" any specific condition, walk away — that's not how the science or the regulation actually reads.
What Stem Cell Therapy Is Used For (Honest Read)
| Indication | Evidence quality | Realistic expectation |
|---|---|---|
| Knee osteoarthritis | Moderate-growing — multiple positive trials | Pain and function improvement over 6–18 months; not a substitute for replacement if joint is end-stage |
| Rotator cuff partial-thickness tears | Moderate | Real but variable; best alongside PT |
| Tendinopathy (Achilles, patellar, elbow) | Moderate | Real, sometimes dramatic; best after failed conservative care |
| Hip OA (not advanced) | Thin but emerging | Variable |
| Spinal disc degeneration | Thin | Variable; image-guided injection required |
| Anti-aging / systemic IV "stem cell drip" | Thin to none | Marketing-heavy; honestly, not the indication where evidence supports it |
| Cardiovascular regeneration | Experimental | Research stage; not appropriate for clinic-level offering |
| Autoimmune disease | Experimental | Same |
| Anti-aging in the broad sense | Marketing-driven | Be skeptical |
The honest pattern: stem cell therapy has the most credible evidence for localized orthopedic indications — joints, tendons, ligaments injected under image guidance. Systemic IV "stem cell" infusions for anti-aging or general wellness have far thinner evidence and are where the marketing-to-medicine gap is widest.
How Much Does Stem Cell Therapy Cost in Utah?
Direct answer: dramatic range from $1,999 per joint at budget clinics to $25,000+ for comprehensive systemic protocols. The Utah-specific landscape:
| Treatment | Typical Utah pricing |
|---|---|
| Single-joint Wharton's Jelly injection (knee, shoulder, hip) | $2,000–$5,000 |
| Bilateral joint protocol | $3,500–$8,500 |
| Multi-joint or systemic + targeted protocol | $7,500–$15,000 |
| IV "stem cell drip" / systemic infusion | $4,000–$12,000 |
| Bone marrow concentrate (BMAC) — same-day in-office | $3,000–$6,000 per joint |
| Adipose-derived (with mini-liposuction) | $6,000–$15,000+ |
| Initial consult + imaging + labs | $300–$800 |
Pricing red flags:
- Under $1,500 per joint for a Wharton's Jelly product — either the cell count is very low, the product is exosome-only mislabeled as "stem cell," or the source is unverifiable
- Over $25,000 for routine orthopedic indications without exceptional credentialing — paying for marketing
- Aggressive package pressure ("buy 3 protocols today, save $X") — high-pressure sales is a tell
Insurance: essentially none. Stem cell injections for orthopedic indications are considered investigational by every major U.S. payer. HSA/FSA reimbursement occasionally accepted with a Letter of Medical Necessity, plan-dependent.
Who Stem Cell Therapy Is Appropriate For
Reasonable candidates:
- Knee, shoulder, or hip osteoarthritis — early-to-moderate stages, after conservative care has been tried, before joint replacement is on the table
- Persistent tendinopathy that has failed PT, NSAIDs, and (often) prior PRP
- Partial-thickness rotator cuff tears in patients who want to delay or avoid surgery
- Athletes recovering from soft-tissue injury who want to accelerate return-to-play
Not appropriate candidates:
- End-stage joint destruction (bone-on-bone, severe deformity) — surgical territory; stem cells will not regrow a destroyed joint
- Active or recent cancer — relative-to-absolute contraindication depending on cancer type and oncology input
- Active infection in or near the target site
- Pregnancy
- Bleeding disorders uncontrolled
- Anyone seeking stem cell injections for a serious systemic medical condition as a substitute for evidence-based care
- Patients seeking IV "stem cell drips" for anti-aging — we'll have an honest conversation about whether the cost is worth the thin evidence
Stem Cell Providers in the Draper / Salt Lake Area
Honest landscape as of May 2026:
- Elements Med Lounge — Draper. Wharton's Jelly protocols for select orthopedic indications, NP-C-led, MD-directed.
- Wellness and Neuro Center — Draper. Stem cell and human cellular tissue therapy.
- BioRestoration — Draper. Stem cell injections within broader regenerative menu.
- The Stem Cell Club — St. George + Park City. Published $1,999 single-protocol pricing — known for high-volume, lower-cost model.
- Joint Regeneration Center of Utah — Salt Lake. Orthopedic-focused, image-guided.
- Relief Medical Group — Utah-wide.
- Stem Cells of Utah — Salt Lake region.
- RUMA Medical — Lehi. Multi-modal regenerative including stem cell.
This is not an endorsement of specific clinical work — it's an acknowledgment that all of the above are licensed practices offering stem cell injection therapy. Use the questions below to vet whichever you choose.
The 6 Questions to Ask Any Stem Cell Clinic Before Booking
1. Which specific product / tissue manufacturer do you use?
Acceptable: a named manufacturer with a publishable safety record. Vague: "we use the best one available."
2. What's the cell viability and cell count per dose at the time of injection?
A reputable product comes with a Certificate of Analysis. Ask to see it. Wharton's Jelly products vary widely — some manufacturers deliver tens of millions of viable MSCs per dose, others under a million.
3. Is the procedure image-guided (ultrasound or fluoroscopy)?
For joint and tendon injections — yes, this should be standard. Blind injections have higher rates of incorrect placement.
4. Who's performing the injection and what's their training?
For orthopedic indications, ideally an MD/DO with image-guided injection experience. For NP/PA injections, ask about their specific training and oversight.
5. What's your protocol for adverse events?
A real clinic has documented protocols for post-injection infection, allergic reaction, and disappointing response. Ask what they look like.
6. What does the published literature actually show for my specific indication?
A clinician who can walk you through the evidence (and its limits) for your specific knee, shoulder, or tendon is the right kind. A clinician who only quotes patient testimonials is not.
What to Expect at a Stem Cell Appointment
A typical Elements timeline for a knee or shoulder protocol:
- Visit 1 (60 min) — comprehensive intake, exam, imaging review (MRI or ultrasound), risk-benefit discussion, informed consent. We don't inject at visit 1 — we want you to think about the cost and the trade-offs.
- Visit 2 — procedure day (60–90 min) — sterile prep, local anesthetic, ultrasound-guided injection. Most patients describe procedure pain as 3–5 out of 10.
- Aftercare — 48–72 hours of relative rest, no NSAIDs for 1–2 weeks (NSAIDs blunt the response), graduated PT starting at day 5–7.
- Follow-up at 6 weeks, 3 months, and 6 months — outcome measurement, additional sessions if indicated.
Common side effects:
- Soreness, swelling at the injection site (24–72 hours)
- Temporary flare of symptoms before improvement
- Mild fatigue day 1–2
- Bruising
Rare:
- Infection (proper sterile technique reduces to extremely low risk)
- Allergic reaction to product components
- No response — variable across patients, sometimes despite ideal candidacy
Frequently Asked Questions
Are stem cell injections FDA-approved?
No. The FDA does not have an approved stem cell drug for orthopedic, cosmetic, or systemic indications outside of a handful of specific blood/hematopoietic applications (bone marrow transplant for leukemia, etc.). Wharton's Jelly and adipose products are typically sold as human cellular tissue products — a legal category, but not "FDA-approved therapies". Any clinic claiming their stem cells are FDA-approved is misrepresenting the regulatory status.
Are Wharton's Jelly stem cells ethical?
Wharton's Jelly comes from the gelatinous matrix of the umbilical cord at full-term healthy births, after the parents donate the cord that would otherwise be discarded. No embryonic tissue is involved, no abortion is involved, the donor mother and baby are both unharmed. The ethical concerns around 2000s-era embryonic stem cells don't apply to Wharton's Jelly products.
Will stem cell injections regrow cartilage in my knee?
Honest answer: probably not in the literal regrowth sense. The published mechanism is more likely modulation of the joint inflammatory environment, reduction of pain, possible thickening of synovial tissue, and slowing of degeneration — rather than dramatic cartilage regeneration. Some imaging studies show modest cartilage thickness improvements; most clinical outcomes are measured in pain and function, not imaging.
How long do stem cell results last?
Variable. For knee OA, the published response duration is typically 6–18 months. Some patients see effects that fade gradually; others see persistent improvement. Repeat injections are common at 6–12 month intervals.
Stem cells vs. PRP — which should I get for my knee?
For mild-to-moderate knee OA, PRP is the cheaper and often equally effective first-line. For knee OA that hasn't responded to PRP, or for more advanced OA where you're trying to delay replacement, stem cell injection has more upside. We often recommend trying PRP first.
Can I travel to Mexico or Panama for cheaper stem cells?
You can, and many patients do — overseas clinics sometimes offer dramatic price reductions and use products (live cells expanded in culture, higher doses) that are not legal in U.S. clinics. The trade-offs: less regulatory oversight, harder to verify quality, no recourse if something goes wrong, travel costs and complications. Not endorsing or condemning — but going in eyes-open is essential. Don't assume cheaper is comparable.
What's the difference between stem cells and exosomes?
Stem cells are live cells with the potential to differentiate and secrete signaling molecules. Exosomes are small extracellular vesicles secreted by stem cells containing growth factors and microRNA. Exosomes are arguably more shelf-stable, easier to standardize, and produce a more predictable cytokine signal — but they're not "stem cells." Both are sometimes used in regenerative practice; they're different products.
How long does the procedure take?
A single joint injection is typically 30–45 minutes including prep. IV stem cell infusion is 60–90 minutes. Combined protocols can take half a day.
Why This Article Exists
Stem cell therapy is the regenerative medicine area with the widest gap between marketing claims and clinical evidence. Patients arrive expecting science-fiction outcomes, and clinics — under competitive pressure — often don't correct that expectation. The honest version: stem cell injections are a real, evolving area with credible (but variable) evidence for specific orthopedic indications, a restrictive FDA position, real costs, and real limits. If a clinic isn't willing to have that conversation up front, that's the signal to keep looking.
Book a free 15-minute stem cell screening consult at Elements Med Lounge: elementsmedlounge.com/contact · (801) 860-4134 · 11576 S. State Street, Suite 101B, Draper, UT.
Sharon Maxwell, NP-C is the founder and clinical lead of Elements Med Lounge in Draper, Utah. Regenerative medicine protocols including stem cell therapy are medically directed by Richard Maxwell, MD, board-certified physician. This article is informational and not a substitute for in-person medical evaluation. FDA regulatory status and pricing accurate as of May 2026; confirm at consult.